Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.

Abstract

Mycobacterium xenopi is a water-related mycobacterium with low pathogenicity in humans.

Little is known about the association between anti-tumour necrosis factor (TNF)alpha and non-tuberculous mycobacterial infections.

The case history is presented of fatal M xenopi infection in a patient receiving anti-TNFalpha treatment.

Full Text

• DOI - Thorax (DOI)
• EBSCO - full-text online (subscription/membership/fee required)
• HighWire Press - full-text online (subscription/membership/fee required)
• Ovid Technologies, Inc. - full-text online (subscription/membership/fee required)

Subjects

• Aged
• Antirheumatic Agents
• Arthritis, Rheumatoid
• Fatal Outcome
• Humans
• Immunoglobulin G
• Immunosuppressive Agents
• Male
• Mycobacterium Infections, Atypical
• Mycobacterium xenopi
• Opportunistic Infections
• Receptors, Tumor Necrosis Factor
• Tuberculosis, Pulmonary

Similar articles

• Mycobacterium xenopi infection of a 50-year-old oil plombage complicated by bronchopleural and pleurocutaneous fistulas. (1999-11-04)
• Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. (2004-06-29)
• First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. (2001-02-22)
• [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]. (2013-02-01)
• Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy. (2012-11-05)
• Spondylodiscitis caused by Mycobacterium xenopi. (2008-09-24)
• Radiographic findings in patients with acquired immunodeficiency syndrome, pulmonary infection, and microbiologic evidence of Mycobacterium xenopi. (1999-02-02)
• The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. (2011-05-02)
• Role of Mycobacterium xenopi disease in patients with HIV infection at the time of highly active antiretroviral therapy (HAART). Comparison with the pre-Haart period. (2003-09-15)

Authors

• Nimrod Maimon
• James Brunton
• Adrienne K Chan
• Theodore K Marras

Publication date

2007-08-09

Journal

Journal topics

• Thorax

Language

Eng.

Copyright

Thorax

Division of Respirology, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada.

Release reference

Thorax. 2007 Aug;62(8):739-40

Related books

• Books of Antirheumatic Agents
• Books of Arthritis, Rheumatoid
• Books of Fatal Outcome
• Books of Immunoglobulin G
• Books of Immunosuppressive Agents
• Books of Mycobacterium Infections, Atypical
• Books of Mycobacterium xenopi
• Books of Opportunistic Infections
• Books of Receptors, Tumor Necrosis Factor
• Books of Thorax
• Books of Tuberculosis, Pulmonary